Shanghai MicroPort MedBot at 3-1/2 months peak on robust revenue growth

Shanghai MicroPort MedBot (Group)

22/01/2026 04:34

** Shares of Shanghai MicroPort MedBot 2252.HK rise 6.3% to HK$32.86, their highest point since October 9

** China-based surgical robots maker expects 2025 revenue to rise 110%-120% y/y

** Its core product Toumai Laparoscopic Surgical Robot has made progress in commercialisation and achieved rapid growth in sales

** Co expects adjusted net loss of not more than 240 mln yuan ($34.5 mln) for 2025 vs 482 mln yuan in 2024, amid rapid revenue rise, lower product costs and operating expenses

** YTD, stock up 31.3%, benchmark Hang Seng Index .HSI up 3.6%

($1 = 6.9617 Chinese yuan renminbi)

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))